12:00 AM
 | 
May 03, 1999
 |  BC Week In Review  |  Company News  |  Deals

InSite, University of California deal

ISV obtained a one-year option to receive exclusive worldwide therapeutic rights to issued and pending university patents covering the TIGR...

Read the full 76 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >